US 12134650
Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
granted A61KA61K35/17A61K47/6803
Quick answer
US patent 12134650 (Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
- Grant date
- Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K35/17, A61K47/6803, A61K47/6849, A61P